Novo Nordisk Announces More Than EUR 400 Million Expansion in Its Manufacturing Facility in Athlone, Ireland
Novo Nordisk announced an investment of EUR 432 million in its facility in Monksland, Athlone, Ireland. This tabletting facility will provide significant additional manufacturing capacity for current...